
Abcellera Biologics Inc
NASDAQ:ABCL

Wall Street
Price Targets
ABCL Price Targets Summary
Abcellera Biologics Inc
According to Wall Street analysts, the average 1-year price target for
ABCL
is 12.24 USD
with a low forecast of 5.05 USD and a high forecast of 29.4 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABCL's stock price target?
Price Target
12.24
USD
According to Wall Street analysts, the average 1-year price target for
ABCL
is 12.24 USD
with a low forecast of 5.05 USD and a high forecast of 29.4 USD.
What is Abcellera Biologics Inc's Revenue forecast?
Projected CAGR
24%
For the last 5 years the
compound annual growth rate for
Abcellera Biologics Inc's revenue is
20%.
The projected
CAGR
for the next 3 years is
24%.